Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urinary-based Assay for Albendazole Coverage
NCT04041427Phase 1Completed
- Sponsor
- Universidad Nacional de Salta
- Start
- Jul 2019
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of albendazole in soil-transmitted helminthiasis (STH) (3 arms), sponsored by Universidad Nacional de Salta. Primary endpoints: Urine albendazole levels at 96 hours and Serum albendazole levels at 72 hours. Started Jul 2019; status: completed.
02
Drugs
albendazole
03
Conditions
soil-transmitted helminthiasis (STH)
Beyond the preview
Go deeper on NCT04041427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04041427.